Neutrophil specific granule and NETosis defects in gray platelet syndrome.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
26 01 2021
Historique:
received: 27 05 2020
accepted: 06 12 2020
entrez: 26 1 2021
pubmed: 27 1 2021
medline: 15 5 2021
Statut: ppublish

Résumé

Gray platelet syndrome (GPS) is an autosomal recessive bleeding disorder characterized by a lack of α-granules in platelets and progressive myelofibrosis. Rare loss-of-function variants in neurobeachin-like 2 (NBEAL2), a member of the family of beige and Chédiak-Higashi (BEACH) genes, are causal of GPS. It is suggested that BEACH domain containing proteins are involved in fusion, fission, and trafficking of vesicles and granules. Studies in knockout mice suggest that NBEAL2 may control the formation and retention of granules in neutrophils. We found that neutrophils obtained from the peripheral blood from 13 patients with GPS have a normal distribution of azurophilic granules but show a deficiency of specific granules (SGs), as confirmed by immunoelectron microscopy and mass spectrometry proteomics analyses. CD34+ hematopoietic stem cells (HSCs) from patients with GPS differentiated into mature neutrophils also lacked NBEAL2 expression but showed similar SG protein expression as control cells. This is indicative of normal granulopoiesis in GPS and identifies NBEAL2 as a potentially important regulator of granule release. Patient neutrophil functions, including production of reactive oxygen species, chemotaxis, and killing of bacteria and fungi, were intact. NETosis was absent in circulating GPS neutrophils. Lack of NETosis is suggested to be independent of NBEAL2 expression but associated with SG defects instead, as indicated by comparison with HSC-derived neutrophils. Since patients with GPS do not excessively suffer from infections, the consequence of the reduced SG content and lack of NETosis for innate immunity remains to be explored.

Identifiants

pubmed: 33496751
pii: S2473-9529(21)00072-0
doi: 10.1182/bloodadvances.2020002442
pmc: PMC7839360
doi:

Substances chimiques

Blood Proteins 0
NBEAL2 protein, human 0
Nbeal2 protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

549-564

Subventions

Organisme : British Heart Foundation
ID : RP-PG-0310-1002
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/09/12/28096
Pays : United Kingdom

Informations de copyright

© 2021 by The American Society of Hematology.

Références

Trends Immunol. 2019 Jul;40(7):584-597
pubmed: 31153737
J Immunol. 2008 Sep 15;181(6):3793-803
pubmed: 18768832
J Cell Biol. 2010 Nov 1;191(3):677-91
pubmed: 20974816
Blood. 2013 Oct 17;122(16):2784-94
pubmed: 24009232
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Platelets. 2006 Feb;17(1):14-9
pubmed: 16308182
Blood. 2020 Oct 22;136(17):1956-1967
pubmed: 32693407
J Clin Invest. 2014 Oct;124(10):4539-48
pubmed: 25244098
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Blood. 2020 Aug 6;136(6):715-725
pubmed: 32384141
Blood. 1993 Jun 1;81(11):3122-9
pubmed: 8098969
Front Immunol. 2018 Mar 29;9:588
pubmed: 29651288
Traffic. 2013 Jul;14(7):749-66
pubmed: 23521701
J Thromb Haemost. 2010 Aug;8(8):1786-96
pubmed: 20524979
Blood. 2018 Mar 1;131(9):1000-1011
pubmed: 29187380
Cell Rep. 2018 Sep 4;24(10):2784-2794
pubmed: 30184510
Elife. 2017 Jun 02;6:
pubmed: 28574339
Blood. 2009 Sep 24;114(13):2619-22
pubmed: 19541821
Hum Mutat. 2017 Oct;38(10):1402-1411
pubmed: 28585318
Annu Rev Immunol. 2011;29:1-21
pubmed: 20936972
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
J Leukoc Biol. 2013 Oct;94(4):711-21
pubmed: 23650620
Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2435-2447
pubmed: 30354215
J Allergy Clin Immunol. 2019 Nov;144(5):1364-1376
pubmed: 31201888
Blood. 1994 Dec 1;84(11):3885-94
pubmed: 7524751
Blood. 2014 Jul 24;124(4):590-7
pubmed: 24948657
J Immunol. 1992 Jan 1;148(1):72-7
pubmed: 1370172
Nat Rev Immunol. 2018 Feb;18(2):134-147
pubmed: 28990587
Science. 2004 Mar 5;303(5663):1532-5
pubmed: 15001782
Blood. 2001 Sep 1;98(5):1382-91
pubmed: 11520786
Platelets. 2004 Aug;15(5):333-40
pubmed: 15370105
Blood. 2010 Dec 2;116(23):4990-5001
pubmed: 20709904
Trends Immunol. 2019 Jul;40(7):648-664
pubmed: 31155315
Blood. 2013 Nov 7;122(19):3349-58
pubmed: 23861251
J Clin Invest. 2017 Sep 1;127(9):3521-3526
pubmed: 28783043
Blood. 2013 Jul 4;122(1):109-11
pubmed: 23687090
Nat Med. 2014 May;20(5):511-7
pubmed: 24784231
Trends Cancer. 2017 Feb;3(2):149-160
pubmed: 28718445
Nat Genet. 2011 Jul 17;43(8):735-7
pubmed: 21765411
Blood. 2014 Dec 4;124(24):3624-35
pubmed: 25258341
Science. 2014 Sep 26;345(6204):1251033
pubmed: 25258084
J Immunol. 2015 Jul 1;195(1):80-6
pubmed: 26019275
J Cell Biol. 2007 Jan 15;176(2):231-41
pubmed: 17210947
Nat Genet. 2011 Jul 17;43(8):738-40
pubmed: 21765413
Blood. 2007 May 15;109(10):4181-90
pubmed: 17244686
Nat Commun. 2018 Sep 14;9(1):3767
pubmed: 30218080
Cell Rep. 2019 Nov 19;29(8):2505-2519.e4
pubmed: 31747616
Nat Immunol. 2014 Nov;15(11):1017-25
pubmed: 25217981
Sci Rep. 2017 Jul 26;7(1):6529
pubmed: 28747804
Blood. 2015 Oct 15;126(16):1967-9
pubmed: 26472737

Auteurs

Cathelijn E M Aarts (CEM)

Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.

Kate Downes (K)

Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom.

Arie J Hoogendijk (AJ)

Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.

Evelien G G Sprenkeler (EGG)

Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.
Emma Children's Hospital, Department of Pediatric Immunology, Rheumatology and Infectious Disease, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Roel P Gazendam (RP)

Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.

Rémi Favier (R)

Assistance Publique-Hôpitaux de Paris, Centre de Reference des Pathologies Plaquettaires, Hôpitaux Armand Trousseau, Bicêtre, Robert Debré, Paris, France.
INSERM Unité Mixte de Recherche (UMR) 1170, Gustave Roussy Cancer Campus, Universite Paris-Saclay, Villejuif, France.

Marie Favier (M)

Assistance Publique-Hôpitaux de Paris, Centre de Reference des Pathologies Plaquettaires, Hôpitaux Armand Trousseau, Bicêtre, Robert Debré, Paris, France.
INSERM Unité Mixte de Recherche (UMR) 1170, Gustave Roussy Cancer Campus, Universite Paris-Saclay, Villejuif, France.

Anton T J Tool (ATJ)

Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.

John L van Hamme (JL)

Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.

Myrto A Kostadima (MA)

Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.

Kate Waller (K)

Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.

Barbara Zieger (B)

Department of Pediatrics and Adolescent Medicine, University Medical Center, Freiburg, Germany.

Maaike G J M van Bergen (MGJM)

Department of Laboratory Medicine, Laboratory of Hematology, Radboud Institute of Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Saskia M C Langemeijer (SMC)

Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.

Bert A van der Reijden (BA)

Department of Laboratory Medicine, Laboratory of Hematology, Radboud Institute of Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Hans Janssen (H)

Division of Cell Biology, Netherlands Cancer Institute, Amsterdam, The Netherlands; and.

Timo K van den Berg (TK)

Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.

Robin van Bruggen (R)

Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.

Alexander B Meijer (AB)

Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.

Willem H Ouwehand (WH)

Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.

Taco W Kuijpers (TW)

Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.
Emma Children's Hospital, Department of Pediatric Immunology, Rheumatology and Infectious Disease, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH